These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36828547)

  • 1. Antagonism between Prdm16 and Smad4 specifies the trajectory and progression of pancreatic cancer.
    Hurwitz E; Parajuli P; Ozkan S; Prunier C; Nguyen TL; Campbell D; Friend C; Bryan AA; Lu TX; Smith SC; Razzaque MS; Xu K; Atfi A
    J Cell Biol; 2023 Apr; 222(4):. PubMed ID: 36828547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells.
    Chen YW; Hsiao PJ; Weng CC; Kuo KK; Kuo TL; Wu DC; Hung WC; Cheng KH
    BMC Cancer; 2014 Mar; 14():181. PubMed ID: 24625091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer.
    Bardeesy N; Cheng KH; Berger JH; Chu GC; Pahler J; Olson P; Hezel AF; Horner J; Lauwers GY; Hanahan D; DePinho RA
    Genes Dev; 2006 Nov; 20(22):3130-46. PubMed ID: 17114584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGIF1 functions as a tumor suppressor in pancreatic ductal adenocarcinoma.
    Parajuli P; Singh P; Wang Z; Li L; Eragamreddi S; Ozkan S; Ferrigno O; Prunier C; Razzaque MS; Xu K; Atfi A
    EMBO J; 2019 Jul; 38(13):e101067. PubMed ID: 31268604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of Bioinformatics Resources Reveals the Therapeutic Benefits of Gemcitabine and Cell Cycle Intervention in SMAD4-Deleted Pancreatic Ductal Adenocarcinoma.
    Hsieh YY; Liu TP; Chou CJ; Chen HY; Lee KH; Yang PM
    Genes (Basel); 2019 Sep; 10(10):. PubMed ID: 31569425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer.
    Liang C; Shi S; Qin Y; Meng Q; Hua J; Hu Q; Ji S; Zhang B; Xu J; Yu XJ
    Gut; 2020 May; 69(5):888-900. PubMed ID: 31611300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tif1γ suppresses murine pancreatic tumoral transformation by a Smad4-independent pathway.
    Vincent DF; Gout J; Chuvin N; Arfi V; Pommier RM; Bertolino P; Jonckheere N; Ripoche D; Kaniewski B; Martel S; Langlois JB; Goddard-Léon S; Colombe A; Janier M; Van Seuningen I; Losson R; Valcourt U; Treilleux I; Dubus P; Bardeesy N; Bartholin L
    Am J Pathol; 2012 Jun; 180(6):2214-21. PubMed ID: 22469842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes.
    Eyres M; Lanfredini S; Xu H; Burns A; Blake A; Willenbrock F; Goldin R; Hughes D; Hughes S; Thapa A; Vavoulis D; Hubert A; D'Costa Z; Sabbagh A; Abraham AG; Blancher C; Jones S; Verrill C; Silva M; Soonawalla Z; Maughan T; Schuh A; Mukherjee S; O'Neill E
    Gastroenterology; 2021 Aug; 161(2):653-668.e16. PubMed ID: 33915173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells.
    Li L; Li Z; Kong X; Xie D; Jia Z; Jiang W; Cui J; Du Y; Wei D; Huang S; Xie K
    Gastroenterology; 2014 Aug; 147(2):485-97.e18. PubMed ID: 24859161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad4-dependent suppressor pituitary homeobox 2 promotes PPP2R2A-mediated inhibition of Akt pathway in pancreatic cancer.
    Wang Q; Li J; Wu W; Shen R; Jiang H; Qian Y; Tang Y; Bai T; Wu S; Wei L; Zang Y; Zhang J; Wang L
    Oncotarget; 2016 Mar; 7(10):11208-22. PubMed ID: 26848620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of canonical Smad4 signaling promotes KRAS driven malignant transformation of human pancreatic duct epithelial cells and metastasis.
    Leung L; Radulovich N; Zhu CQ; Wang D; To C; Ibrahimov E; Tsao MS
    PLoS One; 2013; 8(12):e84366. PubMed ID: 24386371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatase PPM1A is a novel prognostic marker in pancreatic ductal adenocarcinoma.
    Fan J; Yang MX; Ouyang Q; Fu D; Xu Z; Liu X; Mino-Kenudson M; Geng J; Tang F
    Hum Pathol; 2016 Sep; 55():151-8. PubMed ID: 27195906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.
    Kojima K; Vickers SM; Adsay NV; Jhala NC; Kim HG; Schoeb TR; Grizzle WE; Klug CA
    Cancer Res; 2007 Sep; 67(17):8121-30. PubMed ID: 17804724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMAD4 represses FOSL1 expression and pancreatic cancer metastatic colonization.
    Dai C; Rennhack JP; Arnoff TE; Thaker M; Younger ST; Doench JG; Huang AY; Yang A; Aguirre AJ; Wang B; Mun E; O'Connell JT; Huang Y; Labella K; Talamas JA; Li J; Ilic N; Hwang J; Hong AL; Giacomelli AO; Gjoerup O; Root DE; Hahn WC
    Cell Rep; 2021 Jul; 36(4):109443. PubMed ID: 34320363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGFB1-induced autophagy affects the pattern of pancreatic cancer progression in distinct ways depending on SMAD4 status.
    Liang C; Xu J; Meng Q; Zhang B; Liu J; Hua J; Zhang Y; Shi S; Yu X
    Autophagy; 2020 Mar; 16(3):486-500. PubMed ID: 31177911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AGR2 is a SMAD4-suppressible gene that modulates MUC1 levels and promotes the initiation and progression of pancreatic intraepithelial neoplasia.
    Norris AM; Gore A; Balboni A; Young A; Longnecker DS; Korc M
    Oncogene; 2013 Aug; 32(33):3867-76. PubMed ID: 22945649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMAD4 endows TGF-β1-induced highly invasive tumor cells with ferroptosis vulnerability in pancreatic cancer.
    Chen HD; Ye Z; Hu HF; Fan GX; Hu YH; Li Z; Li BR; Ji SR; Zhou CJ; Xu XW; Yu XJ; Qin Y
    Acta Pharmacol Sin; 2024 Apr; 45(4):844-856. PubMed ID: 38057506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of chromosome 18 abnormalities in the progression of pancreatic adenocarcinoma.
    Sunamura M; Lefter LP; Duda DG; Morita R; Inoue H; Yokoyama T; Yatsuoka T; Abe T; Egawa S; Furukawa T; Fukushige S; Oshimura M; Horii A; Matsuno S
    Pancreas; 2004 Apr; 28(3):311-6. PubMed ID: 15084978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMAD4 Y353C promotes the progression of PDAC.
    Wang Z; Li Y; Zhan S; Zhang L; Zhang S; Tang Q; Li M; Tan Z; Liu S; Xing X
    BMC Cancer; 2019 Nov; 19(1):1037. PubMed ID: 31684910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1.
    Radke DI; Ungefroren H; Helm O; Voigt S; Alp G; Braun H; Hübner S; Dilchert J; Sebens S; Adam D; Kalthoff H; Trauzold A
    Cell Signal; 2016 Nov; 28(11):1652-62. PubMed ID: 27492861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.